Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure

被引:12
|
作者
Canbay, A [1 ]
Bechmann, LP [1 ]
Best, J [1 ]
Jochum, C [1 ]
Treichel, U [1 ]
Gerken, G [1 ]
机构
[1] Univ Hosp Essen, Div Gastroenterol & Hepatol, Essen, Germany
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2006年 / 44卷 / 03期
关键词
NASH; NAFLD; IBD; liver failure; Crohn's disease;
D O I
10.1055/s-2006-926502
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) commonly is associated with chronic inflammatory bowel disease (CIBD) and usually is considered to be stable and benign. However, NAFLD - and in particular its subset, non-alcoholic steatohepatitis (NASH) - may lead to progressive liver disease. Moreover, NAFLD sensitizes the liver to injury and increases the risk of developing acute-on-chronic liver failure following a "third hit". We here present one patient with NASH, as probably induced by long-standing Crohn's disease in the absence of ethanol consumption or abuse. The patient acquired an acute HBV infection and died from complications. As based on the clinical and histological findings, Crohn's disease appears to be a risk factor for developing NAFLD and thus to contribute to the progression into NASH. In conclusion, we suggest that Crohn's disease-related NAFLD may increase the vulnerability of the liver, which indicates that patients with a known history of CIBD merit special attention.
引用
收藏
页码:245 / 248
页数:4
相关论文
共 50 条
  • [31] Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research
    Flessa, Christina-Maria
    Nasiri-Ansari, Narjes
    Kyrou, Ioannis
    Leca, Bianca M.
    Lianou, Maria
    Chatzigeorgiou, Antonios
    Kaltsas, Gregory
    Kassi, Eva
    Randeva, Harpal S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (24)
  • [32] Gastrointestinal complications of obesity: Non-alcoholic fatty liver disease (NAFLD) and its sequelae
    Karlas, Thomas
    Wiegand, Johannes
    Berg, Thomas
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 27 (02) : 195 - 208
  • [33] Beverages and Non-alcoholic fatty liver disease (NAFLD): Think before you drink
    Chhimwal, Jyoti
    Patial, Vikram
    Padwad, Yogendra
    CLINICAL NUTRITION, 2021, 40 (05) : 2508 - 2519
  • [34] Non-alcoholic fatty liver disease: A sign of systemic disease
    Reccia, Isabella
    Kumar, Jayant
    Akladios, Cherif
    Virdis, Francesco
    Pai, Madhava
    Habib, Nagy
    Spalding, Duncan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2017, 72 : 94 - 108
  • [35] Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
    Valenzuela-Vallejo, Laura
    Sanoudou, Despina
    Mantzoros, Christos S.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [36] Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
    Roderburg, Christoph
    Krieg, Sarah
    Krieg, Andreas
    Demir, Muenevver
    Luedde, Tom
    Kostev, Karel
    Loosen, Sven H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [37] Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
    Christoph Roderburg
    Sarah Krieg
    Andreas Krieg
    Münevver Demir
    Tom Luedde
    Karel Kostev
    Sven H. Loosen
    European Journal of Medical Research, 28
  • [38] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [39] Predictors of non-alcoholic fatty liver disease (NAFLD) among children with obesity
    Mohamed, Rashdan Zaki
    Jalaludin, Muhammad Yazid
    Zaini, Azriyanti Anuar
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2020, 33 (02): : 247 - 253
  • [40] The Role of Resolvins, Protectins and Marensins in Non-Alcoholic Fatty Liver Disease (NAFLD)
    Maciejewska-Markiewicz, Dominika
    Stachowska, Ewa
    Hawrylkowicz, Viktoria
    Stachowska, Laura
    Prowans, Piotr
    BIOMOLECULES, 2021, 11 (07)